All In Biotech

Free tool

FAERS Monitor: Zovirax

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018604 or its brand name (Zovirax, Acyclovir). Reports on generic versions are filed under their own applications.

Reports

115,336

Serious

83,639

73% of reports

Hospitalization

42,811

Death reported

14,680

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue8,096
  • diarrhoea7,417
  • off label use6,407
  • pneumonia5,695
  • nausea5,651
  • pyrexia4,977
  • death4,923
  • drug ineffective4,759
  • rash4,308
  • dyspnoea3,608
  • asthenia3,360
  • headache3,298
  • neutropenia3,274
  • white blood cell count decreased3,223
  • platelet count decreased3,097

Reports by year received

View as table
YearReports
2004879
20051,014
20061,020
20071,070
20081,327
20091,364
20101,424
20112,412
20122,446
20131,808
20142,467
20155,584
20165,828
20176,979
20188,210
20199,100
20209,880
202111,357
202210,637
20238,757
20248,201
20258,328
20265,242

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,938,823 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
white blood cell count decreasedSignal3,2235.65.411,744
platelet count decreasedSignal3,0975.45.210,911
neutropeniaSignal3,2744.54.38,674
pneumoniaSignal5,6953.23.28,835
pyrexiaSignal4,9772.62.65,108
diarrhoeaSignal7,4172.12.14,405
fatigue8,0961.91.93,581
rash4,3081.81.81,579
asthenia3,3601.61.6836
off label use6,4071.31.3563
nausea5,6511.31.3413
dyspnoea3,6081.21.184
death4,9231.01.09
headache3,2981.00.96
drug ineffective4,7590.70.6904

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.